Article Text

Download PDFPDF
Insulin-like growth factor I gene promoter polymorphism, collagen type II α1 (COL2A1) gene, and the prevalence of radiographic osteoarthritis: the Rotterdam Study
  1. G Zhai6,
  2. F Rivadeneira5,
  3. J J Houwing-Duistermaat1,
  4. I Meulenbelt3,
  5. C Bijkerk4,
  6. A Hofman1,
  7. J B J van Meurs2,
  8. A G Uitterlinden2,
  9. H A P Pols2,
  10. P E Slagboom3,
  11. C M van Duijn1
  1. 1Department of Epidemiology and Biostatistics, Erasmus Medical Centre, Rotterdam, Netherlands
  2. 2Department of Internal Medicine, Erasmus Medical Centre
  3. 3Department of Molecular Epidemiology, Leiden University Medical Centre, Leiden, Netherlands
  4. 4Department of Rheumatology, University Medical Centre St Radboud, Nijmegen, Netherlands
  5. 5Instituto de Genetica Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogota, Colombia
  6. 6Netherlands Institute for Health Sciences, Rotterdam, Netherlands
  1. Correspondence to:
    Professor Cornelia M van Duijn
    Department of Epidemiology and Biostatistics, Erasmus Medical Centre, Postbus 1738, 3000DR, Rotterdam, Netherlands;


Objective: To examine the role of an IGF-I gene promoter polymorphism in the prevalence of radiographic osteoarthritis (ROA), and study its interaction with the COL2A1 gene.

Methods: Individuals genotyped for IGF-I (n = 1546) and COL2A1 gene polymorphisms (n = 808) were selected from a random sample (n = 1583) derived from the Rotterdam study. The presence of ROA was defined as a Kellgren score of 2 or more in at least one of four joints (knee, hip, hand, and spine). Genotype specific odds ratios (OR) were adjusted for age, sex, body mass index, and bone mineral density using logistic regression. Interaction with the COL2A1 genotype was tested.

Results: Overall, no association was found between the IGF-I polymorphism and ROA. In subjects aged 65 years or younger (n = 971), the prevalence of ROA increased with the absence of the 192 base pair (bp) allele (p for trend = 0.03). Compared with homozygotes for the 192 bp allele, the prevalence of ROA was 1.4 times higher in heterozygotes (95% confidence interval, 1.0 to 1.8) and 1.9 times higher in non-carriers (1.1 to 3.3). There was evidence of interaction between the IGF-I and COL2A1 genes. Individuals with the risk genotype of both genes had an increased prevalence of ROA (OR 3.4 (1.1 to 10.7)). No effect was observed in subjects older than 65 years.

Conclusions: Subjects with genetically determined low IGF-I expression (non-carriers of the 192 bp allele) may be at increased risk of ROA before the age of 65 years. Furthermore, an interaction between the IGF-I and COL2A1 genes is suggested.

  • IGF-I
  • COL2A1
  • radiographic osteoarthritis
  • BMD, bone mineral density
  • BMI, body mass index
  • PCR, polymerase chain reaction
  • ROA, radiographic osteoarthritis
  • VNTR, variable number of tandem repeats

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.